<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40">Some current funding mechanisms and initiatives have been extremely successful. For instance, the Gavi, the Vaccine Alliance created innovative financing mechanisms such as the International Finance Facility for Immunisation, which raises funds by issuing bonds in the capital markets [
 <xref ref-type="bibr" rid="CR27">27</xref>]. It was also the midwife to advance market commitments that help the development and manufacture of new and better vaccines for use in LMICs by guaranteeing a market, reducing unpredictability or volatility of demand, and increasing competition and innovation between companies and organizations [
 <xref ref-type="bibr" rid="CR28">28</xref>â€“
 <xref ref-type="bibr" rid="CR30">30</xref>]. Advance market commitments greatly accelerated the introduction of pneumococcal conjugate vaccine and have the potential to dramatically accelerate the introduction of new vaccines and technologies into LMICs. The PAHO Revolving Fund for Vaccine Procurement, which pools the resources of 41 countries and territories, has enabled the procurement of supplies at the lowest prices for the whole Region of the Americas.
</p>
